Overview

Chemotherapy in Treating Patients With Liver Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of cisplatin and epinephrine administered directly into the tumor in treating patients who have primary liver cancer that cannot be removed during surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Matrix Pharmaceutical
Treatments:
Cisplatin
Epirubicin